Brain proton magnetic resonance spectroscopy of alcohol use disorders

Handbook of Clinical Neurology

Volumn 125, Issue , 2014, Pages 313-337

  Meyerhoff, Dieter J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alcohol dependence; Alcohol use disorders; Brain metabolites; Comorbidity; Magnetic resonance spectroscopy; Neuroimaging; Nicotine; Recovery; Relapse; Smoking

Indexed keywords

ALCOHOL-RELATED DISORDERS; ANIMAL; BRAIN; CROSS-SECTIONAL STUDY; HUMAN; LONGITUDINAL STUDY; METABOLISM; PATHOLOGY; PROCEDURES; PROTON NUCLEAR MAGNETIC RESONANCE;

ALCOHOL-RELATED DISORDERS; ANIMALS; BRAIN; CROSS-SECTIONAL STUDIES; HUMANS; LONGITUDINAL STUDIES; PROTON MAGNETIC RESONANCE SPECTROSCOPY;

EID: 84907987572     PISSN: 00729752     EISSN: 22124152     Source Type: Book Series    
DOI: 10.1016/B978-0-444-62619-6.00019-7     Document Type: Chapter

References (185)

1. Abé C., Mon A., Durazzo T.C., et al. Polysubstance and alcohol dependence: unique differences in magnetic resonance-derived brain metabolite concentrations. Drug Alcohol Depend 2013, 130:30-37.
2. Agarwal N., Renshaw P.F. Proton MR spectroscopy-detectable major neurotransmitters of the brain: biology and possible clinical applications. AJNR Am J Neuroradiol 2012, 33:595-602.
3. Baler R.D., Volkow N.D. Drug addiction: the neurobiology of disrupted self-control. Trends Mol Med 2006, 12:559-566.
4. Balestrino M., Lensman M., Parodi M., et al. Role of creatine and phosphocreatine in neuronal protection from anoxic and ischemic damage. Amino Acids 2002, 23:221-229.
5. Bartsch A.J., Homola G., Biller A., et al. Manifestations of early brain recovery associated with abstinence from alcoholism. Brain 2007, 130:36-47.
6. Baslow M.H. Brain N-acetylaspartate as a molecular water pump and its role in the etiology of Canavan disease: a mechanistic explanation. J Mol Neurosci 2003, 21:185-190.
7. Baslow M.H. N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res 2003, 28:941-953.
8. Baslow M.H., Guilfoyle D.N. Using proton magnetic resonance imaging and spectroscopy to understand brain "activation". Brain Lang 2007, 102:153-164.
9. Batouli S.A., Sachdev P.S., Wen W., et al. The heritability of brain metabolites on proton magnetic resonance spectroscopy in older individuals. Neuroimage 2012, 62:281-289.
10. Bauer L.O., Covault J., Harel O., et al. Variation in GABRA2 predicts drinking behavior in project MATCH subjects. Alcohol Clin Exp Res 2007, 31:1780-1787.
11. Behar K.L., Rothman D.L., Petersen K.F., et al. Preliminary evidence of low cortical GABA levels in localized 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients. Am J Psychiatry 1999, 156:952-954.
12. Benarroch E.E. N-acetylaspartate and N-acetylaspartylglutamate: neurobiology and clinical significance. Neurology 2008, 70:1353-1357.
13. Bendszus M., Weijers H.G., Wiesbeck G., et al. Sequential MR imaging and proton MR spectroscopy in patients who underwent recent detoxification for chronic alcoholism: correlation with clinical and neuropsychological data. AJNR Am J Neuroradiol 2001, 22:1926-1932.
14. Bertolino A., Callicott J.H., Mattay V.S., et al. The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biol Psychiatry 2001, 49:39-46.
15. Bierut L.J., Dinwiddie S.H., Begleiter H., et al. Familial transmission of substance dependence: alcohol, marijuana, cocaine, and habitual smoking: a report from the Collaborative Study on the Genetics of Alcoholism. Arch Gen Psychiatry 1998, 55:982-988.
16. Boettiger C.A., Mitchell J.M., Tavares V.C., et al. Immediate reward bias in humans: fronto-parietal networks and a role for the catechol-O-methyltransferase 158(Val/Val) genotype. J Neurosci 2007, 27:14383-14391.
17. Brand A., Richter-Landsberg C., Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993, 15:289-298.
18. Brenner R.E., Munro P.M., Williams S.C., et al. The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio. Magn Reson Med 1993, 29:737-745.
19. Choi C., Bhardwaj P.P., Kalra S., et al. Measurement of GABA and contaminants in gray and white matter in human brain in vivo. Magn Reson Med 2007, 58:27-33.
20. Cosgrove K.P., Esterlis I., Mason G.F., et al. Neuroimaging insights into the role of cortical GABA systems and the influence of nicotine on the recovery from alcohol dependence. Neuropharmacology 2011, 60:1318-1325.
21. Daeppen J.B., Smith T.L., Danko G.P., et al. Clinical correlates of cigarette smoking and nicotine dependence in alcohol-dependent men and women. The Collaborative Study Group on the Genetics of Alcoholism. Alcohol Alcohol 2000, 35:171-175.
22. Dawson D.A., Goldstein R.B., Grant B.F. Rates and correlates of relapse among individuals in remission from DSM-IV alcohol dependence: a 3-year follow-up. Alcohol Clin Exp Res 2007, 31:2036-2045.
23. De Stefano N., Matthews P.M., Arnold D.L. Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995, 34:721-727.
24. De Witte P. Imbalance between neuroexcitatory and neuroinhibitory amino acids causes craving for ethanol. Addict Behav 2004, 29:1325-1339.
25. Di Sclafani V., Finn P., Fein G. Treatment-naive active alcoholics have greater psychiatric comorbidity than normal controls but less than treated abstinent alcoholics. Drug Alcohol Depend 2008, 98:115-122.
26. Dlugos C.A., Pentney R.J. Morphometric evidence that the total number of synapses on Purkinje neurons of old F344 rats is reduced after long-term ethanol treatment and restored to control levels after recovery. Alcohol Alcohol 1997, 32:161-172.
27. Duka T., Trick L., Nikolaou K., et al. Unique brain areas associated with abstinence control are damaged in multiply detoxified alcoholics. Biol Psychiatry 2011, 70:545-552.
28. Durazzo T.C., Meyerhoff D.J. Neurobiological and neurocognitive effects of chronic cigarette smoking and alcoholism. Front Biosci 2007, 12:4079-4100.
29. Durazzo T.C., Gazdzinski S., Banys P., et al. Cigarette smoking exacerbates chronic alcohol-induced brain damage: a preliminary metabolite imaging study. Alcohol Clin Exp Res 2004, 28:1849-1860.
30. Durazzo T.C., Gazdzinski S., Banys P., et al. Brain metabolite concentrations and neurocognition during short-term recovery from alcohol dependence: preliminary evidence of the effects of concurrent chronic cigarette smoking. Alcohol Clin Exp Res 2006, 30:539-551.
31. Durazzo T.C., Rothlind J.C., Gazdzinski S., et al. A comparison of neurocognitive function in nonsmoking and chronically smoking short-term abstinent alcoholics. Alcohol 2006, 39:1-11.
32. Durazzo T.C., Gazdzinski S., Meyerhoff D.J. The neurobiological and neurocognitive consequences of chronic cigarette smoking in alcohol use disorders. Alcohol Alcohol 2007, 42:174-185.
33. Durazzo T.C., Gazdzinski S., Yeh P.H., et al. Combined neuroimaging, neurocognitive and psychiatric factors to predict alcohol consumption following treatment for alcohol dependence. Alcohol Alcohol 2008, 43:683-691.
34. Durazzo T.C., Pathak V., Gazdzinski S., et al. Metabolite levels in the brain reward pathway discriminate those who remain abstinent from those who resume hazardous alcohol consumption after treatment for alcohol dependence. J Stud Alcohol Drugs 2010, 71:278-289.
35. Durazzo T., Gazdzinski S., Mon A., et al. Cortical perfusion in alcohol-dependent individuals during short-term abstinence: relationships to resumption of hazardous drinking after treatment. Alcohol 2010, 44:201-210.
36. Durazzo T., Hutchison K., Fryer S., et al. Associations of cigarette smoking and polymorphisms in brain-derived neurotrophic factor and catechol-O-methyltransferase with neurocognition in alcohol dependent individuals during early abstinence. Front Pharmacol 2012, 3(178).
37. Durazzo T.C., Mon A., Gazdzinski S., et al. Chronic cigarette smoking in alcohol dependence: associations with cortical thickness and N-acetylaspartate levels in the extended brain reward system. Addict Biol 2013, 18:379-391.
38. Ende G., Braus D.F., Walter S., et al. Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia. Schizophr Res 2000, 41:389-395.
39. Ende G., Welzel H., Walter S., et al. Monitoring the effects of chronic alcohol consumption and abstinence on brain metabolism: a longitudinal proton magnetic resonance spectroscopy study. Biol Psychiatry 2005, 58:974-980.
40. Ende G., Walter S., Welzel H., et al. Alcohol consumption significantly influences the MR signal of frontal choline-containing compounds. Neuroimage 2006, 32:740-746.
41. Epperson C.N., O'Malley S., Czarkowski K.A., et al. Sex, GABA, and nicotine: the impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy. Biol Psychiatry 2005, 57:44-48.
42. Fabricius K., Pakkenberg H., Pakkenberg B. No changes in neocortical cell volumes or glial cell numbers in chronic alcoholic subjects compared to control subjects. Alcohol Alcohol 2007, 42:400-406.
43. Falkenberg L.E., Westerhausen R., Specht K., et al. Resting-state glutamate level in the anterior cingulate predicts blood-oxygen level-dependent response to cognitive control. Proc Natl Acad Sci U S A 2012, 109:5069-5073.
44. Fein G., Landman B. Treated and treatment-naive alcoholics come from different populations. Alcohol 2005, 35:19-26.
45. Fein G., Meyerhoff D.J. Ethanol in human brain by magnetic resonance spectroscopy: correlation with blood and breath levels, relaxation, and magnetization transfer. Alcohol Clin Exp Res 2000, 24:1227-1235.
46. Fein G., Meyerhoff D.J., Di Sclafani V., et al. 1H magnetic resonance spectroscopic imaging separates neuronal from glial changes in alcohol-related brain atrophy 1994, 227-241. Chapter in NIAAA Research Monograph No. 27/Alcohol and Glial Cells.
47. Fein G., Di Sclafani V., Cardenas V.A., et al. Cortical gray matter loss in treatment-naive alcohol dependent individuals. Alcohol Clin Exp Res 2002, 26:558-564.
48. Ferguson K.J., MacLullich A.M., Marshall I., et al. Magnetic resonance spectroscopy and cognitive function in healthy elderly men. Brain 2002, 125:2743-2749.
49. Fisher S.K., Novak J.E., Agranoff B.W. Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J Neurochem 2002, 82:736-754.
50. Friend K.B., Malloy P.F., Sindelar H.A. The effects of chronic nicotine and alcohol use on neurocognitive function. Addict Behav 2005, 30:193-202.
51. Gallinat J., Kunz D., Lang U.E., et al. Association between cerebral glutamate and human behaviour: the sensation seeking personality trait. Neuroimage 2007, 34:671-678.
52. Gallinat J., Lang U.E., Jacobsen L.K., et al. Abnormal hippocampal neurochemistry in smokers: evidence from proton magnetic resonance spectroscopy at 3 T. J Clin Psychopharmacol 2007, 27:80-84.
53. Gallinat J., Schubert F., Bruhl R., et al. Met carriers of BDNF Val66Met genotype show increased N-acetylaspartate concentration in the anterior cingulate cortex. Neuroimage 2010, 49:767-771.
54. Gazdzinski S., Durazzo T.C., Weiner M.W., et al. Are treated alcoholics representative of the entire population with alcohol use disorders? A magnetic resonance study of brain injury. Alcohol 2008, 42:67-76.
55. Gazdzinski S., Durazzo T.C., Yeh P.H., et al. Chronic cigarette smoking modulates injury and short-term recovery of the medial temporal lobe in alcoholics. Psychiatry Res 2008, 162:133-145.
56. Gazdzinski S., Durazzo T.C., Mon A., et al. Body mass index is associated with brain injury in alcohol dependence - a multimodal magnetic resonance study. Alcohol Clin Exp Res 2010, 34:2089-2096.
57. Glass J.M., Adams K.M., Nigg J.T., et al. Smoking is associated with neurocognitive deficits in alcoholism. Drug Alcohol Depend 2006, 82:119-126.
58. Goldstein R.Z., Craig A.D., Bechara A., et al. The neurocircuitry of impaired insight in drug addiction. Trends Cogn Sci 2009, 13:372-380.
59. Goto N., Yoshimura R., Moriya J., et al. Critical examination of a correlation between brain gamma-aminobutyric acid (GABA) concentrations and a personality trait of extroversion in healthy volunteers as measured by a 3 Tesla proton magnetic resonance spectroscopy study. Psychiatry Res 2010, 182:53-57.
60. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003, 160:636-645.
61. Govindaraju V., Young K., Maudsley A.A. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 2000, 13:129-153.
62. Grant B.F., Dawson D.A., Stinson F.S., et al. The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002. Drug Alcohol Depend 2004, 74:223-234.
63. Grimm S., Schubert F., Jaedke M., et al. Prefrontal cortex glutamate and extraversion. Soc Cogn Affect Neurosci 2012, 7:811-818.
64. Gruber O., Hasan A., Scherk H., et al. Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate system. Eur Arch Psychiatry Clin Neurosci 2012, 262:23-31.
65. Haga K.K., Khor Y.P., Farrall A., et al. A systematic review of brain metabolite changes, measured with 1H magnetic resonance spectroscopy, in healthy aging. Neurobiol Aging 2009, 30:353-363.
66. Hanson K.L., Medina K.L., Nagel B.J., et al. Hippocampal volumes in adolescents with and without a family history of alcoholism. Am J Drug Alcohol Abuse 2010, 36:161-167.
67. Harding A.J., Wong A., Svoboda M., et al. Chronic alcohol consumption does not cause hippocampal neuron loss in humans. Hippocampus 1997, 7:78-87.
68. Hariri A.R. The neurobiology of individual differences in complex behavioral traits. Annu Rev Neurosci 2009, 32:225-247.
69. Harper C. The neuropathology of alcohol-specific brain damage, or does alcohol damage the brain?. J Neuropathol Exp Neurol 1998, 57:101-110.
70. Harper C. The neuropathology of alcohol-related brain damage. Alcohol Alcohol 2009, 44:136-140.
71. Harper C., Kril J. Patterns of neuronal loss in the cerebral cortex in chronic alcoholic patients. J Neurol Sci 1989, 92:81-89.
72. Harris B.R., Gibson D.A., Prendergast M.A., et al. The neurotoxicity induced by ethanol withdrawal in mature organotypic hippocampal slices might involve cross-talk between metabotropic glutamate type 5 receptors and N-methyl-D-aspartate receptors. Alcohol Clin Exp Res 2003, 27:1724-1735.
73. Hashimoto J.G., Forquer M.R., Tanchuck M.A., et al. Importance of genetic background for risk of relapse shown in altered prefrontal cortex gene expression during abstinence following chronic alcohol intoxication. Neuroscience 2011, 173:57-75.
74. Hasin D.S., Stinson F.S., Ogburn E., et al. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2007, 64:830-842.
75. Heatherton T.F., Wagner D.D. Cognitive neuroscience of self-regulation failure. Trends Cogn Sci 2011, 15:132-139.
76. Hermann D., Weber-Fahr W., Sartorius A., et al. Translational magnetic resonance spectroscopy reveals excessive central glutamate levels during alcohol withdrawal in humans and rats. Biol Psychiatry 2012, 71:1015-1021.
77. Herting M.M., Schwartz D., Mitchell S.H., et al. Delay discounting behavior and white matter microstructure abnormalities in youth with a family history of alcoholism. Alcohol Clin Exp Res 2010, 34:1590-1602.
78. Hetherington H.P., Newcomer B.R., Pan J.W. Measurements of human cerebral GABA at 4.1 T using numerically optimized editing pulses. Magn Reson Med 1998, 39:6-10.
79. Hoerst M., Weber-Fahr W., Tunc-Skarka N., et al. Glutamate levels in the anterior cingulate cortex correlate with self-reported impulsivity in patients with borderline personality disorder and healthy controls. Arch Gen Psychiatry 2010, 67:946-954.
80. Hugg J.W., Kuzniecky R.I., Gilliam F.G., et al. Normalization of contralateral metabolic function following temporal lobectomy demonstrated by h-1 magnetic resonance spectroscopic imaging. Ann Neurol 1996, V40:236-239.
81. Hurd R., Sailasuta N., Srinivasan R., et al. Measurement of brain glutamate using TE-averaged PRESS at 3T. Magn Reson Med 2004, 51:435-440.
82. Hutchison K.E. Substance use disorders: realizing the promise of pharmacogenomics and personalized medicine. Annu Rev Clin Psychol 2010, 6:577-589.
83. Jagannathan N.R., Desai N.G., Raghunathan P. Brain metabolite changes in alcoholism: an in vivo proton magnetic resonance spectroscopy (MRS) study. Magn Reson Imaging 1996, 14:553-557.
84. Jansen J.F., Backes W.H., Nicolay K., et al. 1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology 2006, 240:318-332.
85. Jensen G.B., Pakkenberg B. Do alcoholics drink their neurons away?. Lancet 1993, 342:1201-1204.
86. John U., Meyer C., Rumpf H.J., et al. Strength of the relationship between tobacco smoking, nicotine dependence and the severity of alcohol dependence syndrome criteria in a population-based sample. Alcohol Alcohol 2003, 38:606-612.
87. Johnson B.A. Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function. CNS Drugs 2005, 19:873-896.
88. Kaiser L.G., Young K., Meyerhoff D.J., et al. A detailed analysis of localized J-difference GABA editing: theoretical and experimental study at 4 T. NMR Biomed 2008, 21:22-32.
89. Kalivas P.W., O'Brien C. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology 2008, 33:166-180.
90. Kam K., Nicoll R. Excitatory synaptic transmission persists independently of the glutamate-glutamine cycle. J Neurosci 2007, 27:9192-9200.
91. Ke Y., Cohen B.M., Lowen S., et al. Biexponential transverse relaxation (T(2)) of the proton MRS creatine resonance in human brain. Magn Reson Med 2002, 47:232-238.
92. Ke Y., Streeter C.C., Nassar L.E., et al. Frontal lobe GABA levels in cocaine dependence: a two-dimensional, J-resolved magnetic resonance spectroscopy study. Psychiatry Res 2004, 130:283-293.
93. Kedia S., Sell M.A., Relyea G. Mono- versus polydrug abuse patterns among publicly funded clients. Subst Abuse Treat Prev Policy 2007, 2:33.
94. Kendler K.S., Prescott C.A., Myers J., et al. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry 2003, 60:929-937.
95. Khiat A., Bard C., Lacroix A., et al. Recovery of the brain choline level in treated Cushing's patients as monitored by proton magnetic resonance spectroscopy. Brain Res 2000, 862:301-307.
96. Korbo L. Glial cell loss in the hippocampus of alcoholics. Alcohol Clin Exp Res 1999, 23:164-168.
97. Kril J.J., Halliday G.M. Brain shrinkage in alcoholics: a decade on and what have we learned?. Prog Neurobiol 1999, 58:381-387.
98. Kril J.J., Harding A.J., Wong A., et al. Is the hippocampus damaged in alcoholics with memory loss?. Alcohol Clin Exp Res 1996, 20:76A.
99. Kroenke C.D., Flory G.S., Park B., et al. Chronic ethanol (EtOH) consumption differentially alters gray and white matter EtOH methyl (1) H magnetic resonance intensity in the primate brain. Alcohol Clin Exp Res 2013, 37:1325-1332.
100. Lee E., Jang D.P., Kim J.J., et al. Alteration of brain metabolites in young alcoholics without structural changes. Neuroreport 2007, 18:1511-1514.
101. Licata S.C., Renshaw P.F. Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction. Ann N Y Acad Sci 2010, 1187:148-171.
102. Loeber S., Duka T., Welzel Marquez H., et al. Effects of repeated withdrawal from alcohol on recovery of cognitive impairment under abstinence and rate of relapse. Alcohol Alcohol 2010, 45:541-547.
103. Maddock R.J., Buonocore M.H. MR spectroscopic studies of the brain in psychiatric disorders. Curr Top Behav Neurosci 2012, (epub ahead of print) PubMed PMID: 22294088.
104. Maisto S.A., Connors G.J. Relapse in the addictive behaviors: integration and future directions. Clin Psychol Rev 2006, 26:229-231.
105. Mann K., Hermann D. Individualised treatment in alcohol-dependent patients. Eur Arch Psychiatry Clin Neurosci 2010, 260(Suppl 2):S116-S120.
106. Mann K., Batra A., Gunthner A., et al. Do women develop alcoholic brain damage more readily than men?. Alcohol Clin Exp Res 1992, 1052-1056.
107. Mansell D., Penk W., Hankin C.S., et al. The illness burden of alcohol-related disorders among VA patients: the veterans health study. J Ambul Care Manage 2006, 29:61-70.
108. Mansfield P. Multi-planar image formation using NMR spin echoes. J Phys C: Solid State Phys 1977, 10:L55-L58.
109. Mansfield P., Maudsley A.A. Medical imaging by NMR. Br J Radiol 1977, 50:188-194.
110. Marjanska M., Auerbach E.J., Valabregue R., et al. Localized 1H NMR spectroscopy in different regions of human brain in vivo at 7 T: T2 relaxation times and concentrations of cerebral metabolites. NMR Biomed 2012, 25:332-339.
111. Martin P.R., Gibbs S.J., Nimmerrichter A.A., et al. Brain proton magnetic resonance spectroscopy studies in recently abstinent alcoholics. Alcohol Clin Exp Res 1995, 19:1078-1082.
112. Mason G.F., Petrakis I.L., de Graaf R.A., et al. Cortical gamma-aminobutyric acid levels and the recovery from ethanol dependence: preliminary evidence of modification by cigarette smoking. Biol Psychiatry 2006, 59:85-93.
113. Maudsley A.A., Govind V., Arheart K.L. Associations of age, gender and body mass with 1H MR-observed brain metabolites and tissue distributions. NMR Biomed 2012, 25:580-593.
114. Mayfield R.D., Harris R.A., Schuckit M.A. Genetic factors influencing alcohol dependence. Br J Pharmacol 2008, 154:275-287.
115. Medina K.L., Shear P.K., Schafer J., et al. Cognitive functioning and length of abstinence in polysubstance dependent men. Arch Clin Neuropsychol 2004, 19:245-258.
116. Mekle R., Mlynarik V., Gambarota G., et al. MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T. Magn Reson Med 2009, 61:1279-1285.
117. Mertens J.R., Lu Y.W., Parthasarathy S., et al. Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls. Arch Intern Med 2003, 163:2511-2517.
118. Meyerhoff D.J., Durazzo T.C. Proton magnetic resonance spectroscopy in alcohol use disorders: a potential new endophenotype?. Alcohol Clin Exp Res 2008, 32:1146-1158.
119. Meyerhoff D., Blumenfeld R., Truran D., et al. Effects of heavy drinking, binge drinking, and family history of alcoholism on regional brain metabolites. Alcohol Clin Exp Res 2004, 28:650-661.
120. Meyerhoff D.J., Durazzo T.C., Hutchison K., et al. Associations between BDNF Val66Met genotype and brain metabolite concentrations in alcohol dependence. Alcohol Clin Exp Res 2011, 35(134A).
121. Mier D., Kirsch P., Meyer-Lindenberg A. Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Mol Psychiatry 2010, 15:918-927.
122. Miguel-Hidalgo J.J., Wei J., Andrew M., et al. Glia pathology in the prefrontal cortex in alcohol dependence with and without depressive symptoms. Biol Psychiatry 2002, 52:1121-1133.
123. Miguel-Hidalgo J.J., Overholser J.C., Meltzer H.Y., et al. Reduced glial and neuronal packing density in the orbitofrontal cortex in alcohol dependence and its relationship with suicide and duration of alcohol dependence. Alcohol Clin Exp Res 2006, 30:1845-1855.
124. Miller B.L. A review of chemical issues in 1H NMR spectroscopy: N-Acetyl-L-aspartate, creatine and choline. NMR Biomed 1991, 4:47-52.
125. Miller B.L., Chang L., Booth R., et al. In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci 1996, 58:1929-1935.
126. Modi S., Bhattacharya M., Kumar P., et al. Brain metabolite changes in alcoholism: localized proton magnetic resonance spectroscopy study of the occipital lobe. Eur J Radiol 2011, 79:96-100.
127. Moffett J.R., Namboodiri M.A., Cangro C.B., et al. Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 1991, 2:131-134.
128. Mon A., Durazzo T., Meyerhoff D.J. Glutamate, GABA, and other cortical metabolite concentrations during early abstinence from alcohol and their associations with neurocognitive changes. Drug Alcohol Depend 2012, 125:27-36.
129. Mon A., Durazzo T.C., Gazdzinski S., et al. Brain-derived neurotrophic factor (BDNF) genotype is associated with lobar gray and white matter volume recovery in abstinent alcohol dependent individuals. Genes Brain Behav 2013, 12:98-107.
130. Moss H.B., Chen C.M., Yi H.Y. Subtypes of alcohol dependence in a nationally representative sample. Drug Alcohol Depend 2007, 91:149-158.
131. O'Neill J., Cardenas V.A., Meyerhoff D.J. Effects of abstinence on the brain: quantitative magnetic resonance imaging and magnetic resonance spectroscopic imaging in chronic alcohol abuse. Alcohol Clin Exp Res 2001, 25:1673-1682.
132. Öz G., Alger J.R., Barker P.B., et al. Clinical proton MR spectroscopy in central nervous system disorders: The MRS Consensus Group. Radiology 2014, 279:658-679. 2013.
133. Pan J.W., Takahashi K. Interdependence of N-acetyl aspartate and high-energy phosphates in healthy human brain. Ann Neurol 2005, 57:92-97.
134. Parks M.H., Dawant B.M., Riddle W.R., et al. Longitudinal brain metabolic characterization of chronic alcoholics with proton magnetic resonance spectroscopy. Alcohol Clin Exp Res 2002, 26:1368-1380.
135. Parsons O.A., Nixon S.J. Cognitive functioning in sober social drinkers: a review of the research since 1986. J Stud Alcohol 1998, 59:180-190.
136. Pettegrew J.W., Kopp S.J., Minshew N.J., et al. 31P nuclear magnetic resonance studies of phosphoglyceride metabolism in developing and degenerating brain: preliminary observations. J Neuropathol Exp Neurol 1987, 46:419-430.
137. Pettegrew J.W., Panchalingam K., Withers G., et al. Changes in brain energy and phospholipid metabolism during development and aging in the Fischer 344 rat. J Neuropathol Exp Neurol 1990, 49:237-249.
138. Pfefferbaum A., Sullivan E.V., Mathalon D.H., et al. Longitudinal changes in magnetic resonance imaging brain volumes in abstinent and relapsed alcoholics. Alcohol Clin Exp Res 1995, 19:1177-1191.
139. Pinto E., Reggers J., Gorwood P., et al. The short allele of the serotonin transporter promoter polymorphism influences relapse in alcohol dependence. Alcohol Alcohol 2008, 43:398-400.
140. Pouwels P.J., Frahm J. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn Reson Med 1998, 39:53-60.
141. Prendergast M.A., Harris B.R., Mayer S., et al. Chronic, but not acute, nicotine exposure attenuates ethanol withdrawal-induced hippocampal damage in vitro. Alcohol Clin Exp Res 2000, 24:1583-1592.
142. Rigotti D.J., Inglese M., Gonen O. Whole-brain N-acetylaspartate as a surrogate marker of neuronal damage in diffuse neurologic disorders. AJNR Am J Neuroradiol 2007, 28:1843-1849.
143. Romberger D.J., Grant K. Alcohol consumption and smoking status: the role of smoking cessation. Biomed Pharmacother 2004, 58:77-83.
144. Room R. Smoking and drinking as complementary behaviours. Biomed Pharmacother 2004, 58:111-115.
145. Rosen Y., Lenkinski R.E. Recent advances in magnetic resonance neurospectroscopy. Neurotherapeutics 2007, 4:330-345.
146. Ross B., Bluml S. Magnetic resonance spectroscopy of the human brain. Anat Rec 2001, 265:54-84.
147. Ross B., Michaelis T. Clinical applications of magnetic resonance spectroscopy. Magn Reson Q 1994, 10:191-247.
148. Rothman D.L., Petroff O.A., Behar K.L., et al. Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci U S A 1993, 90:5662-5666.
149. Sanacora G., Gueorguieva R., Epperson C.N., et al. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 2004, 61:705-713.
150. Sartorius A., Lugenbiel P., Mahlstedt M.M., et al. Proton magnetic resonance spectroscopic creatine correlates with creatine transporter protein density in rat brain. J Neurosci Methods 2008, 172:215-219.
151. Schmaal L., Veltman D.J., Nederveen A., et al. N-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance spectroscopy study. Neuropsychopharmacology 2012, 37:2143-2152.
152. Schubert F., Gallinat J., Seifert F., et al. Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla. Neuroimage 2004, 21:1762-1771.
153. Schuckit M.A., Edenberg H.J., Kalmijn J., et al. A genome-wide search for genes that relate to a low level of response to alcohol. Alcohol Clin Exp Res 2001, 25:323-329.
154. Schuff N., Ezekiel F., Gamst A.C., et al. Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging. Magn Reson Med 2001, 45:899-907.
155. Schwab M.E., Bartholdi D. Degeneration and regeneration of axons in the lesioned spinal cord. Physiol Rev 1996, 76:319-370.
156. Schweinsburg B.C., Taylor M.J., Videen J.S., et al. Elevated myo-inositol in gray matter of recently detoxified but not long-term alcoholics: a preliminary MR spectroscopy study. Alcohol Clin Exp Res 2000, 24:699-770.
157. Schweinsburg B.C., Taylor M.J., Alhassoon O.M., et al. Chemical pathology in brain white matter of recently detoxified alcoholics: a 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury. Alcohol Clin Exp Res 2001, 25:924-934.
158. Schweinsburg B.C., Alhassoon O.M., Taylor M.J., et al. Effects of alcoholism and gender on brain metabolism. Am J Psychiatry 2003, 160:1180-1183.
159. Seitz D., Widmann U., Seeger U., et al. Localized proton magnetic resonance spectroscopy of the cerebellum in detoxifing alcoholics. Alcohol Clin Exp Res 1999, 23:158-163.
160. Simmons M.L., Frondoza C.G., Coyle J.T. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 1991, 45:37-45.
161. Sinha R. How does stress lead to risk of alcohol relapse?. Alcohol Res Curr Rev 2012, 34:432-440.
162. Stern A.J., Savostyanova A.A., Goldman A., et al. Impact of the brain-derived neurotrophic factor Val66Met polymorphism on levels of hippocampal N-acetyl-aspartate assessed by magnetic resonance spectroscopic imaging at 3 Tesla. Biol Psychiatry 2008, 64:856-862.
163. Stinson F.S., Grant B.F., Dawson D.A., et al. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend 2005, 80:105-116.
164. Sullivan E.V. NIAAA Research Monograph No. 34: Human brain vulnerability to alcoholism: Evidence from neuroimaging studies. Review of NIAAA's neuroscience and behavioral research portfolio 2000, 473-508. National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD. A. Noronha, M. Eckardt, K. Warren (Eds.).
165. Sullivan E.V., Zahr N.M. Neuroinflammation as a neurotoxic mechanism in alcoholism: commentary on "Increased MCP-1 and microglia in various regions of human alcoholic brain". Exp Neurol 2008, 213:10-17.
166. Sullivan E.V., Rosenbloom M., Serventi K.L., et al. Effects of age and sex on volumes of the thalamus, pons, and cortex. Neurobiol Aging 2004, 25:185-192.
167. Tessner K.D., Hill S.Y. Neural circuitry associated with risk for alcohol use disorders. Neuropsychol Rev 2010, 20:1-20.
168. Thoma R., Mullins P., Ruhl D., et al. Perturbation of the glutamate-glutamine system in alcohol dependence and remission. Neuropsychopharmacology 2011, 36:1359-1365.
169. Tkác I., Andersen P., Adriany G., et al. In vivo 1H NMR spectroscopy of the human brain at 7 T. Magn Reson Med 2001, 46:451-456.
170. Umhau J.C., Momenan R., Schwandt M.L., et al. Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study. Arch Gen Psychiatry 2010, 67:1069-1077.
171. Venkatesh S.K., Gupta R.K., Pal L., et al. Spectroscopic increase in choline signal is a nonspecific marker for differentiation of infective/inflammatory from neoplastic lesions of the brain. J Magn Reson Imaging 2001, 14:8-15.
172. Vion-Dury J., Meyerhoff D.J., Cozzone P.J., et al. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?. J Neurol 1994, 241:354-371.
173. Volkow N.D., Wang G.J., Begleiter H., et al. High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. Arch Gen Psychiatry 2006, 63:999-1008.
174. Volkow N.D., Wang G.-J., Fowler J.S., et al. Addiction: Beyond dopamine reward circuitry. Proc Natl Acad Sci 2011, 108:15037-15042.
175. Wang J.J., Durazzo T.C., Gazdzinski S., et al. MRSI and DTI: a multimodal approach for improved detection of white matter abnormalities in alcohol and nicotine dependence. NMR Biomed 2009, 22:516-522.
176. Wojnar M., Brower K.J., Strobbe S., et al. Association between Val66Met brain-derived neurotrophic factor (BDNF) gene polymorphism and post-treatment relapse in alcohol dependence. Alcohol Clin Exp Res 2009, 33:693-702.
177. Xia Y., Ma D., Hu J., et al. Effect of metabotropic glutamate receptor 3 genotype on N-acetylaspartate levels and neurocognition in non-smoking, active alcoholics. Behav Brain Funct 2012, 8:42.
178. Xin L., Mlynarik V., Lei H., et al. Influence of regional macromolecule baseline on the quantification of neurochemical profile in rat brain 2010, Paper read at ISMRM, at Stockholm, Sweden.
179. Yeo R.A., Gangestad S.W., Gasparovic C., et al. Rare copy number deletions predict individual variation in human brain metabolite concentrations in individuals with alcohol use disorders. Biol Psychiatry 2011, 70:537-544.
180. Yeo R.A., Thoma R.J., Gasparovic C., et al. Neurometabolite concentration and clinical features of chronic alcohol use: a proton magnetic resonance spectroscopy study. Psychiatry Res 2013, 211:141-147.
181. Zahr N.M., Mayer D., Pfefferbaum A., et al. Low striatal glutamate levels underlie cognitive decline in the elderly: evidence from in vivo molecular spectroscopy. Cereb Cortex 2008, 18:2241-2250.
182. Zahr N.M., Mayer D., Rohlfing T., et al. Brain injury and recovery following binge ethanol: evidence from in vivo magnetic resonance spectroscopy. Biol Psychiatry 2010, 67:846-854.
183. Zahr N.M., Mayer D., Rohlfing T., et al. In vivo glutamate measured with magnetic resonance spectroscopy: behavioral correlates in aging. Neurobiol Aging 2013, 34:1265-1276.
184. Zhu P.J., Chiappinelli V.A. Nicotine modulates evoked GABAergic transmission in the brain. J Neurophysiol 1999, 82:3041-3045.
185. Zywiak W.H., Stout R.L., Trefry W.B., et al. Alcohol relapse repetition, gender, and predictive validity. J Subst Abuse Treat 2006, 30:349-353.